1-(3,5-dimethyl-1,2-oxazol-4-yl)-N-[(1-propylimidazol-2-yl)methyl]ethanamine

C14H22N4O — CID 79237242

IUPAC1-(3,5-dimethyl-1,2-oxazol-4-yl)-N-[(1-propylimidazol-2-yl)methyl]ethanamine
SMILESCCCn1ccnc1CNC(C)c1c(C)noc1C
InChIInChI=1S/C14H22N4O/c1-5-7-18-8-6-15-13(18)9-16-10(2)14-11(3)17-19-12(14)4/h6,8,10,16H,5,7,9H2,1-4H3
InChIKeyBPXFZHQIHFZNRZ-UHFFFAOYSA-N
MW262.36 g/mol
LogP2.75
Rot. Bonds6

About 1-(3,5-dimethyl-1,2-oxazol-4-yl)-N-[(1-propylimidazol-2-yl)methyl]ethanamine

1-(3,5-dimethyl-1,2-oxazol-4-yl)-N-[(1-propylimidazol-2-yl)methyl]ethanamine (PubChem CID 79237242) has the molecular formula C14H22N4O and a molecular weight of 262.36 g/mol. Its IUPAC name is 1-(3,5-dimethyl-1,2-oxazol-4-yl)-N-[(1-propylimidazol-2-yl)methyl]ethanamine.

Molecular Properties

Compound Name1-(3,5-dimethyl-1,2-oxazol-4-yl)-N-[(1-propylimidazol-2-yl)methyl]ethanamine
PubChem CID79237242
Molecular FormulaC14H22N4O
Molecular Weight262.36 g/mol
Exact Mass262.18
IUPAC Name1-(3,5-dimethyl-1,2-oxazol-4-yl)-N-[(1-propylimidazol-2-yl)methyl]ethanamine
SMILESCCCn1ccnc1CNC(C)c1c(C)noc1C
InChIInChI=1S/C14H22N4O/c1-5-7-18-8-6-15-13(18)9-16-10(2)14-11(3)17-19-12(14)4/h6,8,10,16H,5,7,9H2,1-4H3
InChIKeyBPXFZHQIHFZNRZ-UHFFFAOYSA-N
XLogP2.75
TPSA55.88 Ų
H-Bond Donors1
H-Bond Acceptors5
Rotatable Bonds6
Heavy Atoms19
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500262.36
LogP ≤ 52.75
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 105

Analyze 1-(3,5-dimethyl-1,2-oxazol-4-yl)-N-[(1-propylimidazol-2-yl)methyl]ethanamine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

1-(1,5-dimethylpyrazol-4-yl)-N-[(1-propylimidazol-2-yl)methyl]ethanamine
CID 62956669
(1R)-1-(4-chlorophenyl)-N-[(1-propylimidazol-2-yl)methyl]ethanamine
CID 81353111
1-(2,5-dimethylphenyl)-N-[(1-propylimidazol-2-yl)methyl]ethanamine
CID 62956848
N-[(1-propylimidazol-2-yl)methyl]-1-(2H-tetrazol-5-yl)ethanamine
CID 62956864
1-(4-methoxyphenyl)-N-[(1-propylimidazol-2-yl)methyl]ethanamine
CID 66243851
1-(3,5-dimethyl-1,2-oxazol-4-yl)-N-[(4-ethoxyphenyl)methyl]ethanamine
CID 78961504
1-(3-fluorophenyl)-N-[(1-propylimidazol-2-yl)methyl]ethanamine
CID 55152900
(1S)-1-cyclopentyl-N-[(1-propylimidazol-2-yl)methyl]ethanamine
CID 81394730
1-morpholin-4-yl-N-[(1-propylimidazol-2-yl)methyl]propan-2-amine
CID 62956125
N-[[1-(2-pyrazol-1-ylethyl)imidazol-2-yl]methyl]propan-2-amine
CID 62221280
N-[[1-[(3,5-dimethyl-1,2-oxazol-4-yl)methyl]imidazol-2-yl]methyl]-2-methylpropan-2-amine
CID 62222891
1-(4-bromophenyl)-N-[(1-propylimidazol-2-yl)methyl]propan-2-amine
CID 62956131

Frequently Asked Questions

What is the IUPAC name of 1-(3,5-dimethyl-1,2-oxazol-4-yl)-N-[(1-propylimidazol-2-yl)methyl]ethanamine?
The IUPAC name of 1-(3,5-dimethyl-1,2-oxazol-4-yl)-N-[(1-propylimidazol-2-yl)methyl]ethanamine (CID 79237242) is 1-(3,5-dimethyl-1,2-oxazol-4-yl)-N-[(1-propylimidazol-2-yl)methyl]ethanamine.
What is the SMILES notation for 1-(3,5-dimethyl-1,2-oxazol-4-yl)-N-[(1-propylimidazol-2-yl)methyl]ethanamine?
The canonical SMILES for 1-(3,5-dimethyl-1,2-oxazol-4-yl)-N-[(1-propylimidazol-2-yl)methyl]ethanamine is CCCn1ccnc1CNC(C)c1c(C)noc1C.
What is the InChIKey of 1-(3,5-dimethyl-1,2-oxazol-4-yl)-N-[(1-propylimidazol-2-yl)methyl]ethanamine?
The InChIKey is BPXFZHQIHFZNRZ-UHFFFAOYSA-N. The full InChI is InChI=1S/C14H22N4O/c1-5-7-18-8-6-15-13(18)9-16-10(2)14-11(3)17-19-12(14)4/h6,8,10,16H,5,7,9H2,1-4H3.
What are the key properties of 1-(3,5-dimethyl-1,2-oxazol-4-yl)-N-[(1-propylimidazol-2-yl)methyl]ethanamine?
1-(3,5-dimethyl-1,2-oxazol-4-yl)-N-[(1-propylimidazol-2-yl)methyl]ethanamine has a molecular weight of 262.36 g/mol, XLogP of 2.75, 6 rotatable bonds, 1 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for 1-(3,5-dimethyl-1,2-oxazol-4-yl)-N-[(1-propylimidazol-2-yl)methyl]ethanamine is sourced from PubChem (CID 79237242), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).